News Reduction of share capital Staff April 20, 2022 Please read the full announcement in the attached PDF Attachment 2022_12_Reduction_of_share_capital Iframe sync Post navigation Previous: Clover’s Efficacy Data in Previously-Infected Individuals is Published in Lancet Infectious DiseaseNext: Otonomy Reports Positive Top-Line Results from Phase 2a Clinical Trial of OTO-413 in Patients with Hearing Loss More Stories News Robotics Massimo Group Signs Letter of Intent to Acquire 100% of AI technology company FST in Drive to Accelerate Its AI-Powered Mobility and Health Technology Strategy Staff February 3, 2026 EHR Healthcare News Baysient Launches iDose® GEN7.0, Expanding Precision Dosing Platform to 16 Inflammatory Disease Indications Staff February 3, 2026 News From the Founders of Fitbit: Introducing Luffu, Your Guardian for Family Health & Safety Staff February 3, 2026
